Landon Capital’s Analyst Reiterates a Buy Rating on LM Funding America Inc. (NASDAQ: LMFA) Analyst Mohammed Saqib of Landon Capital initiated a Buy rating on LM Funding America (NASDAQ: LMFA) with a price target of $.77.In the report analyst Mohammed Saqib...
Growing trend of asset management acquisitions, Carlyle to acquire majority stake in MAI Capital Management for $2.8 billion Carlyle Group (NASDAQ: CG) has signed an agreement to acquire a majority stake in MAI Capital Management, valuing the wealth management firm at...
Picking sides, Delta picks Amazon Leo for in-flight Wi-Fi in blow to Starlink Delta Air Lines Inc. signed an agreement with Amazon.com Inc. to use its Leo satellite service for in-flight Wi-Fi, marking a significant customer win for the e-commerce company’s space...
The results are in, United Therapeutics stock surges on positive drug trial results United Therapeutics Corporation (NASDAQ: UTHR) shares rose 12% Monday after the company announced its TETON-1 pivotal study of Tyvaso met its primary endpoint for treatment of...
Putting your money where your mouth is, Royalty Pharma partners with J&J on $500M drug development deal Royalty Pharma plc (RPRX) announced a research and development co-funding agreement with Johnson & Johnson for $500 million over 2026 and 2027 to...
